Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
other company data
Title:
Unnamed
Year:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
yes
Type of study:
Buehler test
Justification for non-LLNA method:
N/A

Test material

Constituent 1
Chemical structure
Reference substance name:
Dimethyl malonate
EC Number:
203-597-8
EC Name:
Dimethyl malonate
Cas Number:
108-59-8
Molecular formula:
C5H8O4
IUPAC Name:
dimethyl malonate

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
Weight at study initiation: 376-458 g

Study design: in vivo (non-LLNA)

Induction
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
0.40-0.46 g test substance
1st: Induction 100 %
2nd: Induction 100 %
3rd: Challenge 100 %
Challenge
Route:
epicutaneous, occlusive
Vehicle:
unchanged (no vehicle)
Concentration / amount:
0.40-0.46 g test substance
1st: Induction 100 %
2nd: Induction 100 %
3rd: Challenge 100 %
No. of animals per dose:
10

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
1st reading
Hours after challenge:
24
Group:
other: test group/control group
Dose level:
2.5%,25%,50%,100%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: other: test group/control group. Dose level: 2.5%,25%,50%,100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.
Reading:
1st reading
Hours after challenge:
48
Group:
other: test group/control group
Dose level:
2.5%,25%,50%,100%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: other: test group/control group. Dose level: 2.5%,25%,50%,100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.
Reading:
1st reading
Hours after challenge:
72
Group:
other: test group/control group
Dose level:
2.5%,25%,50%,100%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
no
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 72.0. Group: other: test group/control group. Dose level: 2.5%,25%,50%,100%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: no.

Any other information on results incl. tables

no reaction observed in any of 10 animals

Applicant's summary and conclusion

Interpretation of results:
other: not sensitising